Stock comparison
Medtronic
Vera Therapeutics
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MDT
Medtronic
Market cap
$97.77B
Sector
Healthcare
VERA
Vera Therapeutics
Market cap
$2.71B
Sector
Healthcare
Overall winner
Medtronic MDT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MDT | VERA | Winner |
|---|---|---|---|
| Warren Buffett | 50C | 15F | MDT |
| Benjamin Graham | 57C | 41D | MDT |
| Philip Fisher |
Side-by-side metrics
| Metric | MDT | VERA |
|---|---|---|
| Market cap | $97.77B | $2.71B |
| P/E (TTM) | 21.2x | - |
| EV/EBIT | 20.9x | - |
| ROIC (TTM) | 6.43% | -66.5% |
| Gross margin | 61.95% | 0.0% |
| Net margin | 13.0% | 0.0% |
| Revenue CAGR 5y | 2.73% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MDT leads on
- ROIC (TTM)6.43%vs -66.5%+110%
- Gross margin61.95%vs 0.0%+100%
- Net margin13.0%vs 0.0%+100%
- Dividend yield3.73%vs 0.0%
More like VERA
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.